PTEN and non-small cell lung carcinoma: Similar results were recently reported by Chen and coworkers: they analyzed all somatic genetic mutational status of 113 NSCLC patients in response to CTLA-4/PD-1 blockade and detected PTEN mutations exclusively in non-responders, albeit at a low frequency (6.8%) [123].